GenomicDAO

On October 7th, 2021, Genetica established Southeast Asia's largest genome sequencing center in partnership with Vietnam's National Innovation Center (NIC). This comes alongside the development of GenomicDAO, an AI-powered DeSci platform. The center meets US's highest laboratory standards (CLIA) and complies with Vietnam's privacy regulations, ensuring accurate test results, diagnostics, and information security.

NIC and Genetica signing to cooperate under the witness of Deputy Minister of Planning and Investment Tran Duy Dong and ADB country director in Vietnam Andrew Jeffries

According to Dr. Cao Anh Tuan, CEO of Genetica, the center aims to satisfy the increasing demand for genome sequencing in Southeast Asia while reducing costs by up to 30% compared to US laboratories. The center's genome sequencing results are globally accepted and can be used for medical examination and treatment at major medical facilities and hospitals in foreign countries.

The establishment of a genome sequencing center in Vietnam is a significant milestone for the region‘s medical industry, contributing to the development of precision medicine. The center's advanced technology in AI and molecular biotechnology, advised by scientists from the world's leading universities, will significantly contribute to the research and development of new medicines based on Asian genomes and beyond.

Read original paper: https://vir.com.vn/genetica-brings-southeast-asias-largest-gene-sequencing-centre-to-vietnams-nic-88296.html 

------------------------

About GenomicDAO

GenomicDAO is an AI-Powered DeSci Platform to advance Precision Medicine for Asians.

Decentralizing the Future of Modern Medicine  Linktree: https://linktr.ee/genomicdao

GenomicDAO to empower billions of people to join forces for the advancement of Precision Medicine.

Genetica®, a leading AI biotech company, has launched the decentralized science platform GenomicDAO for Precision Medicine advancement. With the core technology - gene decoding chips, AI, and blockchain, GenomicDAO can empower billions to join forces.

Genetica® captured the Precision Medicine movement with over 100,000 genetic profiles through its proprietary gene decoding services using AI. Meanwhile, GenomicDAO breaks free from the centralization of modern medicine R&D by establishing a community for precision medicine initiatives, in which members can reap financial and medical benefits.

To develop products addressing health causes initiated by its community, GenomicDAO’s ultimate goal is to create genetic insights, personalized recommendations, and precision medicine drugs. Its platform will serve as the launchpad to bootstrap various precision medicine initiatives, followed by a dedicated subsidiary DAO.

Genetica® partnered with Illumina® & Thermo Fisher, two of the world’s leading genomics organizations, and has over 20 products in its portfolio from comprehensive healthcare to sports and early disease prevention. It was awarded The Best AI-Powered Genetic Testing Biotech Company by Global Health & Pharma and is advised by top scientists from world-renowned universities such as UCSF, Harvard, Stanford, and Cornell.

GenomicDAO has kicked off its first initiative – Stroke Prevention – with the official token listing set on February 20, 2023.

________________

About GenomicDAO

GenomicDAO is an AI-Powered DeSci Platform to advance Precision Medicine for Asians.

Decentralizing the Future of Modern Medicine 

Linktree: https://linktr.ee/genomicdao